Who is sponsoring NCT06211907?

NCT06211907 is sponsored by Helse Stavanger HF.

What drugs are being tested in NCT06211907?

Interventions in NCT06211907: Postoperative intraocular tamponade.

What condition does NCT06211907 study?

NCT06211907 studies Macular Holes.

Is NCT06211907 still recruiting?

NCT06211907 is currently recruiting now. Last updated 6 November 2024.

Last reviewed 2024-11-06 · How we verify

NCT06211907

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Small Macular Holes Treated With Air

Recruiting now NA Last updated 6 November 2024

What this trial tests

NA trial testing Postoperative intraocular tamponade in Macular Holes in 132 participants. Currently enrolling.

Timeline

14 July 2024

Primary endpoint
30 June 2028

30 June 2028

Quick facts

Lead sponsor	Helse Stavanger HF
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	132
Start date	14 July 2024
Primary completion	30 June 2028
Estimated completion	30 June 2028
Sites	7 locations across Greece, Spain, Norway

Drugs / interventions tested

Postoperative intraocular tamponade

Conditions studied

Macular Holes — all drugs for Macular Holes →

Sponsor

Helse Stavanger HF — full company profile →

Who can join

18 and older, any sex, with Macular Holes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Non-inferiority trial comparing intraocular air and gas tamponade for closure of macular holes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Macular Holes

Currently open trials in the same condition.

NCT06000111 — Duration of Face Down Positioning for Full-Thickness Macular Hole Repair · NA · recruiting
NCT04904679 — The Use of Amniotic Membrane or Internal Limiting Membrane for Large or Refractory Macular Holes: A Prospective Study · NA · active not recruiting
NCT03713268 — Intraoperative OCT Guidance of Intraocular Surgery II · recruiting

Other Helse Stavanger HF trials

Trials by the same sponsor.

NCT06983002 — Bridging Affect Consciousness, Mentalization and Trauma- Exploring an Integrative Treatment Approach for Personality Dis · NA · not yet recruiting
NCT06774261 — Phenserine on the Alzheimer's Treatment Horizon, Study 1 · Phase 1 · not yet recruiting
NCT06362707 — Fasudil Trial for Treatment of Early Alzheimer's Disease (FEAD) · Phase 2 · recruiting
NCT06150274 — Comparison of Wire Assisted Percutaneous Balloon Mitral Valvulotomy With Standard Inoue Balloon Valvulotomy · NA · completed
NCT06115200 — Norwegian Adult Mental Health Registry · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06211907 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Helse Stavanger HF
Last refreshed: 6 November 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06211907.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing